No Data
No Data
No Data
No Data
No Data
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
cls.cnApr 15 14:37
Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target Is $48
Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48.
MT NewswiresApr 12 22:36
Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)
TipRanksApr 12 13:41
Top 10 Best Performing S&P 500 Health Care Stocks of 2024
Seeking AlphaApr 11 02:56
Novo Nordisk Parent Resubmits Application Seeking US Antirust Nod for Catalent Deal
Novo Nordisk (NOVO-B.CO) parent Novo Nordisk Foundation filed a new application to secure the US Federal Trade Commission's approval on its proposed acquisition of manufacturing subcontractor Catalent
MT NewswiresApr 9 12:05
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks were easing late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each down about 0.2% The iShares Biotechnology ETF (IBB) rose 0.
MT NewswiresApr 9 04:00
No Data
No Data